Epilep­sy and Alzheimer's cell ther­a­py biotech lays off 25% of staff

A Bay Area biotech work­ing on off-the-shelf cell ther­a­pies for epilep­sy, Alzheimer’s and oth­er undis­closed in­di­ca­tions laid off about 25% of its work­force re­cent­ly, Neu­rona …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA